TiGenix is a biomedical company focused on research and development of innovative local treatments for damaged and osteoarthritic joints.
Führungspositionen
Name & Titel
Biographie
Eduardo Bravo
CEO / President
Eduardo Bravo serves as the CEO / President of TiGenix.
Gregory Gordon
Head of Medical Department for U.S.
Dr. Gregory Gordon has been Head of Medical Department for U.S. at TiGenix NV since September 12, 2017. Dr. Gordon has a strong background in clinical and academic medicine and extensive experience in the pharmaceutical industry driving broad-based, cross-functional teams in executing all aspects of clinical development. He joins TiGenix from Nestle Health Science where he was Global Clinical Affairs Lead, Gastrointestinal Health. In this role, he helped design a pharmaceutical development strategy for gastroenterology and oversaw clinical development programs in the GI field. He previously held roles at Stealth BioTherapeutics, Inc., Ironwood Pharmaceuticals and Parexel International. He is a qualified lawyer and member of the New York State Bar. Dr. Gordon was awarded his MD by the State University of New York at Stony Brook School of Medicine.
Lassen Sie TiGenix wissen, dass Sie dort arbeiten möchten
Sagen Sie TiGenix, dass Sie interessiert sind dort zu arbeiten, ihre persönlichen Informationen bleiben dabei anonym. Comparably gibt TiGenix die Gelegenheit, Sie anzustellen. Wenn es eine passende Stelle gibt, matchen wir diese.
Gleichberechtigungs BewertungWie positiv bewerten Frauen ihre Gesamterfahrung mit TiGenix
N/A
Herkunftsvielfalts BewertungWie positiv bewerten Minderheiten ihre Gesamterfahrung mit TiGenix